Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,494 signal articles · 158 in last 24h · 121,966 total before filter · latest 2h ago
158last 24h
1267last 7d
214● bullish (7d)
154● bearish (7d)
205publishers
AllMacro210Earnings439M&A100Regulatory25Product9Analyst13
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Here's What Key Metrics Tell Us About CNH (CNH) Q1 Earnings
Zacks113d agoneutral
Here's What Key Metrics Tell Us About CNH (CNH) Q1 Earnings

While the top- and bottom-line numbers for CNH (CNH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Cigna (CI) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks113d agoneutral
Cigna (CI) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

GE HealthCare Just Crashed 13% on a Guidance Cut. Here’s the Case for Buying the Dip
24/7 Wall St.113d agobearish
GE HealthCare Just Crashed 13% on a Guidance Cut. Here’s the Case for Buying the Dip

GE HealthCare (NASDAQ: GEHC) currently trades at $59.49, well below the Wall Street consensus price target of $89.74. That implies upside of roughly 50.8% if the analysts are right. GE HealthCare is the medical imaging and diagnostics business spun from General Electric, with about $20.6 billion in annual revenue across Advanced Imaging Solutions, Patient Care ... GE HealthCare Just Crashed 13% on a Guidance Cut. Here’s the Case for Buying the Dip

Lemonade Q1 Earnings Call Highlights
MarketBeat113d agoneutral
Lemonade Q1 Earnings Call Highlights

Lemonade (NYSE:LMND) reported what executives described as an “excellent quarter” for the first quarter of 2026, pointing to accelerating growth, improving underwriting results, and narrowing losses as the insurtech continues to scale its portfolio and retain more premium following a reinsurance tra